Copyright The New York Times
Andrew here in London with some of the DealBook team across the pond, Michael de la Merced and Bernhard Warner. There’s big M.&A. news: Kimberly-Clark will buy Kenvue, the maker of Tylenol, for more than $40 billion. We’ve got the details (and some questions). We’re also taking a look at the big showdown at the Supreme Court this week: The government will seek to defend President Trump’s authority to impose tariffs under the International Emergency Economic Powers Act. We’ve got a rundown of the arguments and the implications of the court’s decision. Also, what’s the Fed going to do next month? We take a look at the state of play. A legal showdown S&P 500 futures are up on Monday after the benchmark index notched its sixth straight month of gains. Corporate profits are holding steady, as is consumer spending.
